RNA Targeting Small Molecule Drug Discovery Market, By Indication (Neurological Diseases, Cancer, Metabolic Diseases and Infectious Disease), By Drug (Tomivosertib, Translarna, Risdiplam, ELX-02, ABX464 and H3B-6545), By Route of Administration (Subcutaneous and Oral), By End-user (Academic and Research Institutes and Pharmaceutical and Biopharmaceutical Companies), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
RNA targeting small molecule drug discovery Market size was valued at USD 1,208.1 Million in 2022, expanding at a CAGR of 21.8% from 2023 to 2030.
RNA targeting small molecules drug discovery refers to the process of examining and developing small molecule drugs that specifically inhibit and modulate the function of RNA molecules within cells. RNA, or ribonucleic acid, plays an essential role in several cellular processes, including regulation and gene expression. Moreover, a tiny molecule is an organic compound with a relatively low, molecular weight that can interact with biological targets including nucleic acids or proteins.
RNA Targeting Small Molecule Drug Discovery Market- Market Dynamics
- Several novel techniques and the healthcare sector raising the market demand
To expand the drug ability of RNA molecules various novel techniques have been developed. As a result, numerous small molecules, with the potential of acting on current and novel RNA targets are also being studied in preclinical and clinical studies for the treatment of several indications, including infectious diseases, genetic diseases, and other types of cancers. Thus, such factors may drive the demand for the RNA targeting small molecules drug discovery market. However, the exorbitant cost of medication research is one of the main obstacles to the market growth. Moreover, it is projected that the RNA targeting small molecules drug discovery industry could transform the way the healthcare sector currently treats various diseases. In line with this, these drugs function by selectively targeting RNA molecules, which are appealing targets for drug development as they are important for controlling gene expression.
RNA Targeting Small Molecule Drug Discovery Market- Key Insights
- As per the analysis shared by our research analyst, the global RNA targeting small molecule drug discovery market is estimated to grow annually at a CAGR of around 21.8% over the forecast period (2023-2030)
- This market pioneers the development of drugs that selectively target RNA, presenting a promising approach to tackle diseases with unmet medical needs, such as genetic disorders and certain cancers.
- RNA-targeted small molecules offer new dimensions to drug discovery, complementing traditional approaches and broadening the scope of treatable conditions, ultimately improving patient outcomes.
- On the basis of region, North America was the leading revenue generator in 2022
RNA Targeting Small Molecule Drug Discovery Market- Segmentation Analysis:
The global RNA targeting small molecule drug discovery market is segmented on the basis of indication, drug, route of administration, end-user, and region.
The market is divided into four categories based on indication: neurological diseases, cancer, metabolic diseases, infectious disease, and others. The cancer segment is accounted to dominate the market. As they target cancer cells only and are created to specifically target cancer-related genetic alterations, RNA-targeted drugs have a cutting-edge as compared to other types of cancer treatments in terms of efficacy and side effects reduction. Moreover, for cancer treatment various pharmaceutical companies are investing heavily in RNA-targeted drug discovery, which is likely to fuel the market growth.
The market is categorized into six categories based on the drug: tomivosertib, translarna, risdiplam, ELX-02, ABX464, and H3B-6545. The translarna™ segment is expected to witness the largest revenue share. It is created to treat genetic disorders caused by a particular type of mutation known as a nonsense mutation. Additionally, these mutations can lead to several genetic disorders such as certain types of cystic fibrosis and muscular dystrophy. Moreover, in the mRNA Translarna™ promotes \"read-through\" of the premature stop codon, allowing the ribosome to continue translating and create a full-length, functional protein. This might mitigate the effects of the genetic disorder caused by the nonsense mutation.
The market is segmented into two categories based on the route of administration: subcutaneous and oral. The oral segment is likely to possess the largest revenue share. As it is one of the crucial preferred routes for drug delivery owing to its patient compliance and convenience. The capability to administer small molecule medications easily by oral route, avoidance of invasive procedures, and potentially improved patient adherence to treatment regimens are the advantages of developing oral delivery systems for small molecule medications.
The market is divided into two categories based on end-user: academic and research institutes, pharmaceutical and biopharmaceutical companies, and others. The pharmaceutical and biopharmaceutical companies segment is likely to maintain its dominance over the forecast period. As they have huge experience and resources in terms of drug discovery, and as a result, the segment is expected to continue to dominate the market. There are various small to medium-sized biopharmaceutical sectors penetrating the market.
RNA Targeting Small Molecule Drug Discovery Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
RNA Targeting Small Molecule Drug Discovery Market- Competitive Landscape:
In the competitive RNA-targeting small molecule drug discovery industry, various industries are contending for market dominance. These industries have a substantial presence on the market, based on their resources and experience in the production and development of RNA-targeted pharmaceuticals. Moreover, to introduce new treatments and get regulatory permission, they have developed connections with regulatory organizations and healthcare providers. For instance, in February 2023, ReviR Therapeutics collaborated with Asieris to develop new oncology therapies. Additionally, developing new treatments for genitourinary tumors and other related serious diseases is the aim of this collaboration.
Recent Developments:
- For instance, in January 2023, Atomic AI released a $35 million series for the advancement of an AI-driven RNA structure platform for the treatment of incurable diseases.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET KEY PLAYERS
- PTC Therapeutics
- Accent Therapeutics
- Expansion Therapeutics
- Anima Biotech Inc.
- Servier Laboratories
- Arrakis Therapeutics
- AstraZeneca
- Skyhawk Therapeutics, Inc.
- Epics Therapeutics
- H3 Biomedicine Inc.
- Hoffmann-La Roche Ltd
- Ribometrix
- AC immune
- STORM Therapeutics
GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, BY INDICATION
- Neurological Diseases
- Cancer
- Metabolic Diseases
- Infectious Disease
- Others
GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, BY DRUG
- Tomivosertib
- Translarna
- Risdiplam
- ELX-02
- ABX464
- H3B-6545
GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, BY ROUTE OF ADMINISTRATION
- Subcutaneous
- Oral
- Others
GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, BY END-USER
- Academic and Research Institutes
- Pharmaceutical and Biopharmaceutical Companies
- Others
GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. RNA Targeting Small Molecule Drug Discovery Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. RNA Targeting Small Molecule Drug Discovery Market Snippet by Indication
2.1.2. RNA Targeting Small Molecule Drug Discovery Market Snippet by Drug
2.1.3. RNA Targeting Small Molecule Drug Discovery Market Snippet by Route of Administration
2.1.4. RNA Targeting Small Molecule Drug Discovery Market Snippet by End-user
2.1.5. RNA Targeting Small Molecule Drug Discovery Market Snippet by Country
2.1.6. RNA Targeting Small Molecule Drug Discovery Market Snippet by Region
2.2. Competitive Insights
3. RNA Targeting Small Molecule Drug Discovery Key Market Trends
3.1. RNA Targeting Small Molecule Drug Discovery Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. RNA Targeting Small Molecule Drug Discovery Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. RNA Targeting Small Molecule Drug Discovery Market Opportunities
3.4. RNA Targeting Small Molecule Drug Discovery Market Future Trends
4. RNA Targeting Small Molecule Drug Discovery Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. RNA Targeting Small Molecule Drug Discovery Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. RNA Targeting Small Molecule Drug Discovery Market Landscape
6.1. RNA Targeting Small Molecule Drug Discovery Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. RNA Targeting Small Molecule Drug Discovery Market – By Indication
7.1. Overview
7.1.1. Segment Share Analysis, By Indication, 2022&2030 (%)
7.1.2. Neurological Diseases
7.1.3. Cancer
7.1.4. Metabolic Diseases
7.1.5. Infectious Disease
7.1.6. Others
8. RNA Targeting Small Molecule Drug Discovery Market – By Drug
8.1. Overview
8.1.1. Segment Share Analysis, By Drug, 2022&2030 (%)
8.1.2. Tomivosertib
8.1.3. Translarna™
8.1.4. Risdiplam
8.1.5. ELX-02
8.1.6. ABX464
8.1.7. H3B-6545
9. RNA Targeting Small Molecule Drug Discovery Market – By Route of Administration
9.1. Overview
9.1.1. Segment Share Analysis, By Route of Administration, 2022&2030 (%)
9.1.2. Subcutaneous
9.1.3. Oral
10. RNA Targeting Small Molecule Drug Discovery Market – By End-user
10.1. Overview
10.1.1. Segment Share Analysis, By End-user, 2022&2030 (%)
10.1.2. Academic and Research Institutes
10.1.3. Pharmaceutical and Biopharmaceutical Companies
10.1.4. Others
11. RNA Targeting Small Molecule Drug Discovery Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
11.2. North America
11.2.1. Overview
11.2.2. RNA Targeting Small Molecule Drug Discovery Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.2.4. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.2.5. North America Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.2.6. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.2.7. North America Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. RNA Targeting Small Molecule Drug Discovery Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.3.9. Italy
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.9.3. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.3.9.4. Italy Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.3.9.5. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.9.6. Italy Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.3.10. United Kingdom
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.10.3. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.3.10.4. United Kingdom Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.3.10.5. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.10.6. United Kingdom Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.3.11. France
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.11.3. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.3.11.4. France Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.3.11.5. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.11.6. France Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.3.12. Russia
11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.12.2. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.3.12.3. Russia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.3.12.4. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.12.5. Russia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.3.13. Netherlands
11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.13.2. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.3.13.3. Netherlands Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.3.13.4. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.13.5. Netherlands Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.3.14. Sweden
11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.14.2. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.3.15. Poland
11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.15.2. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.3.15.3. Poland Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.3.15.4. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.15.5. Poland Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.3.16. Rest of Europe
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.16.3. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.3.16.4. Rest of the Europe Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.3.16.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.16.6. Rest of the Europe Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. RNA Targeting Small Molecule Drug Discovery Key Manufacturers in Asia Pacific
11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.4.4. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.4.5. Asia Pacific Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.7. Asia Pacific Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.4.8. India
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.8.3. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.4.8.4. India Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.4.8.5. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.8.6. India Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.4.9. China
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.9.3. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.4.9.4. China Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.4.9.5. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.9.6. China Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.4.13. Thailand
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.13.3. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.4.13.4. Thailand Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.4.13.5. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.13.6. Thailand Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.4.14. Indonesia
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.14.3. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.4.14.4. Indonesia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.4.14.5. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.14.6. Indonesia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.5. Latin America
11.5.1. Overview
11.5.2. RNA Targeting Small Molecule Drug Discovery Key Manufacturers in Latin America
11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.5.4. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.5.5. Latin America Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.5.6. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.5.7. Latin America Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.6. Middle East and Africa
11.6.1. Overview
11.6.2. RNA Targeting Small Molecule Drug Discovery Key Manufacturers in Middle East and Africa
11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.6.4. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.6.5. Middle East and Africa Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.7. Middle East and Africa Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
12. Key Vendor Analysis- RNA Targeting Small Molecule Drug Discovery Industry
12.1. Competitive Dashboard
12.2. Company Profiles
12.2.1. PTC Therapeutics
12.2.2. Accent Therapeutics
12.2.3. Expansion Therapeutics
12.2.4. Anima Biotech Inc.
12.2.5. Servier Laboratories
12.2.6. Arrakis Therapeutics
12.2.7. AstraZeneca
12.2.8. Skyhawk Therapeutics, Inc.
12.2.9. Epics Therapeutics
12.2.10. H3 Biomedicine Inc.
12.2.11. Hoffmann-La Roche Ltd
12.2.12. Ribometrix
12.2.13. AC immune
12.2.14. STORM Therapeutics
13. 360 Degree Analyst View
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
